Orchid Pharma Board Approves Enabling Resolution to Raise up to Rs 600 Crore
Orchid Pharma Ltd 路 Outcome 路 20 Oct 2026, 5:43 pm
Orchid Pharma Board Approves Enabling Resolution to Raise up to Rs 600 Crore The Board of Directors of Orchid Pharma Limited, at its meeting on 20th Oct'26, approved an enabling resolution to explore raising funds for an indicative amount of up to Rs 600 crore. The capital may be raised via equity shares, convertible debentures, or other eligible securities through modes including Qualified Institutions Placement (QIP), private placement, preferential issue, or public issue. The fundraise remains subject to necessary shareholder, statutory, and regulatory approvals.
Original exchange filing (PDF)
More announcements from Orchid Pharma Ltd
- Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited ('the Company') 路 18 Nov 2026
- Board Comments on fine levied by Stock Exchanges 路 17 Nov 2026
- Investor Presentation-Quarter II of FY 2026-27, ended on September 30, 2026 路 17 Nov 2026
- Statement of deviation or variation for the quarter ended on September 30, 2026 on the use of proceeds of funds raised through Qualified institutional placement (QIP) 路 14 Nov 2026
- Declaration of Financial results for quarter and half year ended on September 30, 2026 路 14 Nov 2026
- Outcome of Board Meeting 路 14 Nov 2026
- Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Monitoring Agency Report for the Quarter-II ended on September 30, 2026 路 14 Nov 2026
